Investigation of the Efficacy of Transcranial Magnetic Stimulation in Patients Developing Complex Regional Pain Syndrome Type 1 in the Upper Extremity During the Subacute-Chronic Period After Ischemic Stroke

Launched by ANKARA CITY HOSPITAL BILKENT · Jan 18, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called transcranial magnetic stimulation (TMS) for people who have developed Complex Regional Pain Syndrome (CRPS) in their arms or hands after having an ischemic stroke. CRPS is a condition that causes severe pain and sensitivity in an area of the body, often following an injury or stroke. The researchers want to see if TMS can help reduce pain and improve the quality of life for these patients, especially during the subacute to chronic phase after their stroke.

To join the study, participants need to be between the ages of 65 and 74 and have been diagnosed with both CRPS and ischemic stroke. However, individuals with epilepsy, those who are pregnant, or anyone with certain medical devices like pacemakers cannot participate. If you qualify and decide to join, you can expect to receive TMS treatment during the trial, which is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain. This trial is currently looking for participants, and it aims to find a new and effective way to manage pain for those affected by this challenging condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of Complex Regional Pain Syndrome Diagnosis of ischemic stroke
• Exclusion Criteria:
• • Epilepsy Pregnancy Cardiac Pacemaker, Brain pacemaker, Cochlear Implants